-+ 0.00%
-+ 0.00%
-+ 0.00%
Koa Shoji HoldingsLtd (TSE:9273) Stock Trails Strong Profitability As Margins Ease
Share
Listen to the news

Koa Shoji HoldingsLtd walked into earnings with the stock grinding lower over the past quarter and trading on a modest 8.5x trailing P/E. That set expectations low. The headline today is earnings power, not revenue drama. Trailing net profit margin holds at 15.2% and the stock still sits almost 20% below a discounted cash flow fair value estimate.

The emotional gap is clear. Price action has been cautious while the income statement points to solid, high quality profits. The rest of this report examines whether that disconnect still looks justified after this latest quarter.

Impressed by Koa Shoji HoldingsLtd's 15.2% net margin but cautious about a stock that still trades below a fair value estimate and has struggled in recent months? Compare it with a curated list of resilient, lower risk opportunities in our 56 resilient stocks with low risk scores.

FY 2026 Earnings Summary

  • Revenue (Q4 FY 2026 vs Q4 FY 2025): ¥6,343.946 m vs. ¥5,648.393 m (up about 12.3%)
  • Net Income (Excl. Extra Items, Q4 FY 2026 vs Q4 FY 2025): ¥695.598 m vs. ¥677.269 m (up about 2.7%)
  • Basic EPS (Q4 FY 2026 vs Q4 FY 2025): ¥16.52 vs. ¥16.08 (up about 2.7%)
  • Trailing 12 Month Net Profit Margin (FY 2026 vs prior year): 15.2% vs. 15.6% (margin modestly lower year on year)

Prefer clean charts instead of staring at another wall of earnings tables and ratios for Koa Shoji HoldingsLtd? See how the stock’s valuation compares at a glance in our full visual breakdown via the company report for Koa Shoji HoldingsLtd.

TSE:9273 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:9273 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Koa Shoji earnings support a steady defensive story

The latest Koa Shoji numbers keep the defensive healthcare supply chain story intact. Revenue in Q4 FY 2026 is higher than Q4 FY 2025 and net income and EPS also move in the same direction, even if only modestly. That fits a picture of stable demand across API trading and contract manufacturing rather than sudden acceleration. The 15.2% trailing net margin is slightly lower than last year but still healthy for a B2B pharma supplier, which supports the idea of a resilient, service driven business model.

Margins and share price keep caution in play

The mildly bearish angle around regulation and margin pressure still has some support. Profitability is edging lower with net margin slipping from 15.6% to 15.2%. That hints at cost or pricing pressure in parts of Koa Shoji's portfolio. The share price has also fallen over 7 days, 30 days and 90 days, which shows ongoing market caution even with stable earnings. Together, that mix fits a company with solid operations but limited excitement and a business model that can still face pressure on margins.

With Koa Shoji HoldingsLtd trading at 8.5x P/E and a 15.2% margin, the key question is how robust the balance sheet really is. Verify the cushion behind those earnings in our financial health analysis of Koa Shoji HoldingsLtd stock.

Stay Ahead With Simply Wall St

If you think Koa Shoji HoldingsLtd looks interesting with its 8.5x P/E and 15.2% net margin yet still trading below a fair value estimate, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and wait for a setup that matches your plan. After you take a position, use the Portfolio Command Center to cut through market noise and focus on the updates that actually matter to your holdings. For the longer term, tap into crowd wisdom and see how other investors are thinking through opportunities and risks via the Community. That way you can spot potential catalysts and pressure points early and keep a step ahead of the wider market.

Seeking Alternatives Beyond Koa Shoji HoldingsLtd?

Markets move fast and fresh opportunities can gain breakout momentum before most investors even notice. Scan under the radar for now, before the crowd catches up and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending